Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)

NCT00928200 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Study was terminated due to lack of accrual.

Conditions

Relapsed Acute Lymphoblastic Leukemia
Allergy to PEG e.Coli Asparaginase
Allergy to Native e.Coli Asparaginase

Interventions

DRUG: Erwinase
DRUG: Vincristine
DRUG: Dexamethasone
DRUG: Doxorubicin
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Triple Intrathecal Therapy
DRUG: Dexrazoxane

Sponsor

Therapeutic Advances in Childhood Leukemia Consortium